A 967079 - CAS 1170613-55-4
Catalog number: B0084-359603
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C12H14FNO
Molecular Weight:
207.24
COA:
Inquire
Targets:
TRP Channel
Description:
A 967079 is a selective TRPA1 channel blocker (IC50 = 67 and 289 nM at human and rat TRPA1 receptors, respectively) with 1000-fold selectivity for TRPA1 over other TRP channels. A 967079 was shown to have analgesic effects in a rat osteoarthritic pain model.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-359603 100 mg $399 In stock
Bulk Inquiry
Brife Description:
TRPA1 channel blocker
Purity:
≥98% by HPLC
Synonyms:
A-967079; A 967079; A967079; (1E,3E)-1-(4-Fluorophenyl)-2-methyl-1-pentene-3-one oxime; 1-(4-Fluorophenyl)-2-methyl-1-penten-3-one oxime
MSDS:
Inquire
InChIKey:
HKROEBDHHKMNBZ-CHBKHGQFSA-N
InChI:
InChI=1S/C12H14FNO/c1-3-12(14-15)9(2)8-10-4-6-11(13)7-5-10/h4-8,15H,3H2,1-2H3/b9-8+,14-12+
Canonical SMILES:
CCC(=NO)C(=CC1=CC=C(C=C1)F)C
1.Sites Contributing to TRPA1 Activation by the Anesthetic Propofol Identified by Photoaffinity Labeling.
Woll KA;Skinner KA;Gianti E;Bhanu NV;Garcia BA;Carnevale V;Eckenhoff RG;Gaudet R Biophys J. 2017 Nov 21;113(10):2168-2172. doi: 10.1016/j.bpj.2017.08.040. Epub 2017 Sep 19.
In addition to inducing anesthesia, propofol activates a key component of the pain pathway, the transient receptor potential ankyrin 1 ion channel (TRPA1). Recent mutagenesis studies suggested a potential activation site within the transmembrane domain, near the A-967079 cavity. However, mutagenesis cannot distinguish between protein-based and ligand-based mechanisms, nor can this site explain the complex modulation by propofol. Thus more direct approaches are required to reveal potentially druggable binding sites. Here we apply photoaffinity labeling using a propofol derivative, meta-azipropofol, for direct identification of binding sites in mouse TRPA1. We confirm that meta-azipropofol activates TRPA1 like the parent anesthetic, and identify two photolabeled residues (V954 and E969) in the S6 helix. In combination with docking to closed and open state models of TRPA1, photoaffinity labeling suggested that the A-967079 cavity is a positive modulatory site for propofol. Further, the photoaffinity labeling of E969 indicated pore block as a likely mechanism for propofol inhibition at high concentrations. The direct identification of drug-binding sites clarifies the molecular mechanisms of important TRPA1 agonists, and will facilitate drug design efforts to modulate TRPA1.
2.Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels.
Huang Q;Chen Y;Gong N;Wang YX Metabolism. 2016 Apr;65(4):463-74. doi: 10.1016/j.metabol.2015.12.002. Epub 2015 Dec 17.
OBJECTIVE: ;Methylglyoxal is known to be associated with the development of nephropathy, retinopathy, and other complications in diabetes. The present study tested the hypothesis that endogenously increased levels of methylglyoxal in diabetes are causally associated with the induction of neuropathic pain.;MATERIALS AND METHODS: ;Streptozotocin- and methylglyoxal-induced pain models were established in rats, and the anti-nociceptive effects of the methylglyoxal scavenging agents, selective transient receptor potential channel ankyrin 1 (TRPA1) antagonist, and Nav1.8 antagonist were tested.;RESULTS: ;Systemic injection of streptozotocin in rats induced a prolonged increase in plasma methylglyoxal by approximately 60%, which was correlated with the progressive development of mechanical allodynia and thermal hyperalgesia. Local subcutaneous injection of methylglyoxal into the hindpaw produced dose-dependent and biphasic flinching nociceptive responses, which resembled formaldehyde (formalin)-induced nociception. The local methylglyoxal nociception was significantly blocked by co-injection into the hindpaw of the selective transient receptor potential channel ankyrin 1 (TRPA1) antagonist, A967079, and the Nav1.
3.Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia.
Hamilton NB;Kolodziejczyk K;Kougioumtzidou E;Attwell D Nature. 2016 Jan 28;529(7587):523-7. doi: 10.1038/nature16519. Epub 2016 Jan 13.
The myelin sheaths wrapped around axons by oligodendrocytes are crucial for brain function. In ischaemia myelin is damaged in a Ca(2+)-dependent manner, abolishing action potential propagation. This has been attributed to glutamate release activating Ca(2+)-permeable N-methyl-D-aspartate (NMDA) receptors. Surprisingly, we now show that NMDA does not raise the intracellular Ca(2+) concentration ([Ca(2+)]i) in mature oligodendrocytes and that, although ischaemia evokes a glutamate-triggered membrane current, this is generated by a rise of extracellular [K(+)] and decrease of membrane K(+) conductance. Nevertheless, ischaemia raises oligodendrocyte [Ca(2+)]i, [Mg(2+)]i and [H(+)]i, and buffering intracellular pH reduces the [Ca(2+)]i and [Mg(2+)]i increases, showing that these are evoked by the rise of [H(+)]i. The H(+)-gated [Ca(2+)]i elevation is mediated by channels with characteristics of TRPA1, being inhibited by ruthenium red, isopentenyl pyrophosphate, HC-030031, A967079 or TRPA1 knockout. TRPA1 block reduces myelin damage in ischaemia. These data suggest that TRPA1-containing ion channels could be a therapeutic target in white matter ischaemia.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related TRP Channel Products


CAS 1159996-20-9 TC-I 2000

TC-I 2000
(CAS: 1159996-20-9)

TC-I 2000 is a potent and orally bioactive TRPM8 channel blocker. TC-I 2000 was shown to inhibit icilin-induced TRPM8 channel activation in rTRPM8-expressing CH...

CAS 39711-79-0 WS 3

WS 3
(CAS: 39711-79-0)

WS 3 is a cooling agent that acts as an agonist at TRPM8 receptors (EC50 = 3.7 μM).

CAS 105955-11-1 OLDA

OLDA
(CAS: 105955-11-1)

OLDA is a vanilloid TRPV1 (VR1) receptor agonist with EC50 value of 36 nM at hVR1. OLDA is also a 5-lipoxygenase inhibitor with IC50 value of 7.5 nM.

CAS 1459809-09-6 AC 4

AC 4
(CAS: 1459809-09-6)

AC 4 is a photoswitchable TRPV1 channel blocker (IC50 = 3.1 μM) that converts TRPV1 channels into photoreceptors.

CAS 824982-41-4 A 784168

A 784168
(CAS: 824982-41-4)

A 784168 is a potent and selective TRPV1 antagonist (IC50 = 25 nM for inhibition of TRPV1 activation by 50 nM capsaicin) exhibiting no activity against a range ...

CAS 1190217-35-6 ASP 7663

ASP 7663
(CAS: 1190217-35-6)

ASP 7663 has been found to be a TRPA1 activator and could show abdominal analgesic activities.

CAS 332117-28-9 TCS 5861528

TCS 5861528
(CAS: 332117-28-9)

TCS 5861528 is a selective TRPA1 blocker with IC50 values are 14.3 and 18.7μM respectively), attenuates diabetes mellitus hypersensitivity and displays antinoci...

CAS 128007-31-8 Arvanil

Arvanil
(CAS: 128007-31-8)

Arvanil is a vanilloid TRPV1 (VR1) and cannabinoid CB1 agonist with Ki values of 0.3 and 0.5 μM respectively. It increases lung tidal volume, diaphragm activity...

Chemical Structure

CAS 1170613-55-4 A 967079

Quick Inquiry

Verification code

Featured Items